Zhao et al. reported that POU2AF1 is activated by amplification (or through other mechanisms) and may promote MM progression by accelerating the growth of MM cells through direct transactivation of one of its target genes, TNFRSF17 (Zhao et al., 2008). Here, TNFRSF17 is linked to Miyoshi myopathy.